Singapore markets closed
  • Straits Times Index

    3,294.86
    +0.04 (+0.00%)
     
  • Nikkei

    27,522.26
    -250.67 (-0.90%)
     
  • Hang Seng

    24,965.55
    +13.20 (+0.05%)
     
  • FTSE 100

    7,494.13
    -90.88 (-1.20%)
     
  • BTC-USD

    38,326.15
    -4,627.89 (-10.77%)
     
  • CMC Crypto 200

    897.82
    +655.14 (+269.96%)
     
  • S&P 500

    4,437.03
    -45.70 (-1.02%)
     
  • Dow

    34,510.56
    -204.83 (-0.59%)
     
  • Nasdaq

    13,939.93
    -214.09 (-1.51%)
     
  • Gold

    1,832.10
    -10.50 (-0.57%)
     
  • Crude Oil

    84.77
    -0.78 (-0.91%)
     
  • 10-Yr Bond

    1.7530
    -0.0800 (-4.36%)
     
  • FTSE Bursa Malaysia

    1,527.06
    -0.69 (-0.05%)
     
  • Jakarta Composite Index

    6,726.37
    +99.50 (+1.50%)
     
  • PSE Index

    7,293.52
    +54.24 (+0.75%)
     

Global Smoking Cessation Epidemiology and Patient Flow Report 2021: Focus on US, Germany, France, Italy, Spain, UK, Japan, G7 Countries - ResearchAndMarkets.com

·2-min read

The "Global Smoking Cessation Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering.

Global Smoking Cessation Epidemiology and Patient Flow Analysis - 2021, provides Smoking Cessation epidemiology, demographics, and patient flow. The data is presented by Pharma G7 countries including the US, France, Spain, Italy, UK, Japan.

The research provides population data to characterize Smoking Cessation patients, history of the disease at the population level (Smoking Cessation prevalence, Smoking Cessation incidence) and at the clinical level (from diagnosis to treated patients). It also helps to identify patient sub-groups (age, gender, sub-groups) to understand targeted population for research and development, commercialization.

Research scope:

  • Smoking Cessation patient flow: Smoking Cessation prevalence, diagnosed, and drug-treated patients

  • Countries: US, Germany, France, Italy, Spain, UK, Japan, G7 Countries

  • Demographics: Smoking Cessation patients by age group, gender

  • Forecast: Smoking Cessation epidemiology forecast to 2035

The data from this research will help executives:

  • Establish basis for Smoking Cessation market sizing, assessing market potential, and developing drug forecast models

  • Identify Smoking Cessation patients segments through age groups, gender, and disease sub-types

  • Develop Smoking Cessation population-based health management frameworks

  • Evaluate Smoking Cessation market opportunities, identify target patient population

  • Align marketing decisions with the Smoking Cessation target population

  • Communicate leadership and health authorities about your Smoking Cessation target patient population

Key Topics Covered:

1. Research Methodology

2. Smoking Cessation Patients Definition

3. US Smoking Cessation Epidemiology and Patient Flow

4. Germany Smoking Cessation Epidemiology and Patient Flow

5. France Smoking Cessation Epidemiology and Patient Flow

6. Italy Smoking Cessation Epidemiology and Patient Flow

7. Spain Smoking Cessation Epidemiology and Patient Flow

8. UK Smoking Cessation Epidemiology and Patient Flow

9. Europe Smoking Cessation Epidemiology and Patient Flow

10. Japan Smoking Cessation Epidemiology and Patient Flow

11. Global Smoking Cessation Epidemiology and Patient Flow

12. Sources

For more information about this report visit https://www.researchandmarkets.com/r/7mi6tm

View source version on businesswire.com: https://www.businesswire.com/news/home/20210504005709/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting